Trial Profile
A Prospective, Multi-Centre, Double Blind, Randomized, Placebo Controlled Trial to Evaluate the Safety and Efficacy of ICXP007 in a Phase III Trial With Four-Layer Therapeutic Compression, for the Treatment of Non-Infected Skin Leg Ulcers, Due to Venous-Insufficiency.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs ICX-PRO (Primary)
- Indications Varicose ulcer
- Focus Therapeutic Use
- Acronyms TOPICAL II
- Sponsors Intercytex
- 26 Jul 2020 Status changed from recruiting to completed.
- 21 May 2014 New trial record